Compound Overview
LY3437943, referred to in research literature as Retatrutide, is a synthetic peptide studied as a triple receptor agonist. In research settings, it has been investigated for its interactions with GLP-1, GIP, and glucagon receptors. These receptors are of interest in studies of metabolic and endocrine signaling pathways.
Research has explored its binding properties and effects in controlled laboratory models focused on receptor activation and downstream pathways.
Research Applications
This peptide is of interest in laboratory research focused on:
- Receptor binding affinity and intracellular signaling studies
- In-vitro models exploring metabolic regulation
- Investigations into peptide formulation and stability
All research is conducted under applicable guidelines. No therapeutic claims are made.
Disclaimer: For research purposes only. Not approved by FDA for human consumption. Not for human or veterinary use. Complies with applicable Canadian regulations. 21+.
Order This Compound
99%+ Purity • Third-Party Tested • COA Included
Buy 10 MG — $149.99 Buy 20 MG — $199.99⭐ Multi-vial deal: 2+ vials of this peptide = $10 off per vial (every unit)!